tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Burns, 367 are a BUY (87.8%), 51 are a HOLD (12.2%).
Analyst Robert Burns, carries an average stock price target met ratio of 25.47% that have a potential upside of 39.1% achieved within 99 days. Previously, Robert Burns worked at HC WAINWRIGHT.
Robert Burns’s has documented 843 price targets and ratings displayed on 39 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NRIX, Nurix Therapeutics at 02-Apr-2025.
Analyst best performing recommendations are on PRLD (PRELUDE THERAPEUTICS ).
The best stock recommendation documented was for PRLD (PRELUDE THERAPEUTICS ) at 9/10/2024. The price target of $5 was fulfilled within 1 day with a profit of $0.38 (7.06%) receiving and performance score of 70.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.75
$-0.27 (-13.37%)
$5
7 months 16 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold
7 months 22 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Buy
1 years 3 months 28 days ago
(15-Dec-2023)
0/1 (0%)
$20.97 (87.27%)
1 years 3 months 28 days ago
(15-Dec-2023)
0/1 (0%)
$93 (163.16%)
1 years 3 months 28 days ago
(15-Dec-2023)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Robert Burns is most bullish on?
Which stock is Robert Burns is most reserved on?
What Year was the first public recommendation made by Robert Burns?
